Another study found that the activated EGFR-ERK signaling pathway in GBM upregulates COP9 signalosome subunit 6 (CSN6) and PD-L1 protein expression, stabilizing PD-L1 and inhibiting its degradation (62). Here, CD274 is linked to glioblastoma.